Phenotype of a Homozygous CADASIL Patient in Comparison to 9 Age-Matched Heterozygous Patients With the Same R133C Notch3 Mutation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background and Purpose — CADASIL is an autosomal dominant arteriopathy, characterized by multiple brain infarcts, cognitive decline, and finally dementia, which is caused by mutations in Notch3 gene encoding a Notch3 receptor protein. We describe the clinical, neuropsychological, imaging, genetic, and skin biopsy findings in a CADASIL patient homozygous for the C475T mutation resulting in R133C amino acid substitution, in comparison to 9 age-matched heterozygous patients with the same mutation. Methods — The patients were examined clinically and neuropsychologically and with MRI and positron emission tomography for assessment of cerebral blood flow. The gene defect was analyzed by sequencing the products of polymerase chain reaction of exons 3 and 4 of the Notch3 gene. Dermal arteries were analyzed electron microscopically. Results — The homozygous patient had his first-ever stroke at age 28 years. This is markedly earlier than the average, but the patient’s heterozygous son had his first transient ischemic attack–like episode at the same age and another heterozygous patient had his first-ever stroke when only 2 years older. He was neuropsychologically more severely deteriorated than all but 1 of the heterozygous patients. These 2 patients had the most severe (confluent grade D) white matter MRI changes. Positron emission tomography showed markedly reduced cerebral blood flow. Skin biopsy revealed profuse deposits of granular osmiophilic material. The progression of disease in the homozygous case was, however, slower than in the most severely affected heterozygous patient. Conclusions — Our homozygous patient’s phenotype is within the clinical spectrum of CADASIL, although at its severe end. Thus, CADASIL may follow the classic definition of a dominant disease, according to which the heterozygous and homozygous patients are clinically indistinguishable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)08083-5 · Cited by 682
Clinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669 · cited 1×
“The following neuropsychological tests were used: (1) executive functions: Trail Making Test A (TMTAtim),24 verbal fluency FAS (FAStot)25; (2) verbal abstraction: Wechsler Adult Intelligence Scale, Revised (WAIS-R) similarities (Simil)26; (3) visuospatial ability: Luria clock setting and reading (CloSet, CloRea),27 Re…”
MethodPatterns of MRI lesions in CADASIL
Chabriat, H., Levy, C., Taillia, H., Iba-Zizen, M.-T., Vahedi, K., Joutel, A., Tournier-Lasserve, E., & Bousser, M.-G. (1998) · Neurology · doi:10.1212/wnl.51.2.452 · Cited by 339
SCHELTENS, P., BARKHOF, F., VALK, J., ALGRA, P. R., HOOP, R. G. V. D., NAUTA, J., & WOLTERS, E. C. (1992) · Brain · doi:10.1093/brain/115.3.735 · Cited by 314
Quantitative MRI in CADASIL: Correlation with disability and cognitive performance
Dichgans, M., Filippi, M., Brüning, R., Iannucci, G., Berchtenbreiter, C., Minicucci, L., Uttner, I., Crispin, A., Ludwig, H., Gasser, T., et al. (1999) · Neurology · doi:10.1212/wnl.52.7.1361 · Cited by 120
Cited by
Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088
Di Donato, I., Bianchi, S., De Stefano, N., Dichgans, M., Dotti, M. T., Duering, M., Jouvent, E., Korczyn, A. D., Lesnik-Oberstein, S. A. J., Malandrini, A., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0778-8 · Cited by 287
CADASIL: a Common Form of Hereditary Arteriopathy Causing Brain Infarcts and Dementia
Kalimo, H., Ruchoux, M., Viitanen, M., & Kalaria, R. N. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00451.x · Cited by 266
Self-citationTikka, S., Baumann, M., Siitonen, M., Pasanen, P., Pöyhönen, M., Myllykangas, L., Viitanen, M., Fukutake, T., Cognat, E., Joutel, A., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12181 · Cited by 189
“Besides, the similar phenotype in the homozygous and heterozygous CADASIL patients (126) as well as the lack of truncating mutations in CADASIL (100) also favor a mechanism other than loss of the canonical Notch3 function.”
BackgroundSelf-citationLiao, Y.-C., Hsiao, C.-T., Fuh, J.-L., Chern, C.-M., Lee, W.-J., Guo, Y.-C., Wang, S.-J., Lee, I.-H., Liu, Y.-T., Wang, Y.-F., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136501 · Cited by 123
“In literature, homozygosity of NOTCH3 R133C mutation was reported in a 28 year-old stroke patient at the severe end of clinical spectrum whereas R578C homozygous mutation was found in a 65 year-old men with mild phenotype [27, 28].”
Background
Metadata
- Authors
- Tuominen, S., Juvonen, V., Amberla, K., Jolma, T., Rinne, J. O., Tuisku, S., Kurki, T., Marttila, R., Pöyhönen, M., Savontaus, M.-L., Viitanen, M., & Kalimo, H.
- Venue
- Stroke
- Published
- 2001-08
- Volume
- 32
- Issue
- 8
- Pages
- 1767-1774
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1970664237
- Cited by
- 87
- References
- 6
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.